Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Neetu Ahirwar"'
Publikováno v:
Journal of South Asian Federation of Obstetrics and Gynaecology. 13:110-113
Publikováno v:
Journal of Evolution of Medical and Dental Sciences. 3:1895-1898
Autor:
Neetu Ahirwar
Publikováno v:
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 8:4254
Background: Recently neoadjuvant chemotherapy has started being considered for advanced stage of carcinoma cervix. Drug delivery to pelvic tumour is optimal with neoadjuvant chemotherapy since tumour vascular supply has not been damaged by any previo
Publikováno v:
Journal of Evolution of Medical and Dental Sciences. 3:2153-2155
Autor:
Neetu Ahirwar, Rekha Wadhwani
Publikováno v:
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 7:2192
Background: Emergency peripartum hysterectomy (EPH) is an uncommon obstetric procedure, usually performed as a life-saving measure in cases of intractable obstetric hemorrhage. Obstetrics hysterectomy is performed on gravid uterus during pregnancy la
Autor:
Neetu Ahirwar
Publikováno v:
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 7:1754
Background: Maternal mortality rate in India continues to be a national challenge despite of the various measures taken by the Indian government, Non profit organizations in and outside the country including the World Health Organization. To find out
Publikováno v:
International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 6:1848
Background: India is a developing country and it is growing rapidly in all aspects of life. Health status of population has improved and hence the life expectancy. Women are affected positively by this improvement and their life expectancy has become
Autor:
Pushplata Sankhwar, Sabuhi Qureshi, Nisha Singh, Neetu Ahirwar, Uma S. Singh, Anju Kumari Rani
Publikováno v:
Journal of obstetrics and gynaecology of India. 63(4)
A prospective cohort study in a teaching hospital to assess the efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced carcinoma cervix.Neoadjuvant chemotherapy in the form of cisplatin 75 mg/m(2) and paclitaxel 135 mg/m